Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Syncona Shs GBP ( (GB:SYNC) ) has issued an update.
Syncona Limited announced the purchase of 135,155 of its own ordinary shares as part of its ongoing share buyback programme. The shares, purchased at a uniform price of 95.8318 GBp each, will be held in treasury, impacting the company’s total voting rights, which now stand at 624,258,839. This move is part of Syncona’s strategic efforts to manage its capital structure and enhance shareholder value, reflecting its commitment to long-term returns.
More about Syncona Shs GBP
Syncona Limited is a leading life science investor that focuses on creating, building, and scaling a portfolio of globally leading life science companies. The company aims to extend and enhance human life by delivering transformational treatments to patients, especially in areas of high unmet need. Syncona works closely with world-class academic founders and management teams to develop treatments that provide significant patient impact, maintaining a diversified portfolio of 20-25 life science businesses across various development stages and therapeutic areas.
YTD Price Performance: -11.84%
Average Trading Volume: 767,386
Technical Sentiment Consensus Rating: Buy
See more data about SYNC stock on TipRanks’ Stock Analysis page.
